Latest Breaking News On - Samueld riccitelli - Page 1 : comparemela.com

Biocept Inc appoints Antonino Morales as its president and chief executive officer

Biocept Inc appoints Antonino Morales as its president and chief executive officer
proactiveinvestors.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from proactiveinvestors.com Daily Mail and Mail on Sunday newspapers.

United statesSamueld riccitelliM faye wilsonRobert walshBiocept incUniversity of southern californiaAntonino moralesMazda northSouthern california

Biocept (BIOC) Appoints Antonino Morales as CEO and President

Biocept (BIOC) Appoints Antonino Morales as CEO and President
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesRobert walshSamueld riccitelliM faye wilsonArthur andersenUniversity of southern californiaBiocept incAudit committeeAntonino moralesChief executive officerChief financial officerVice presidentChief financialMazda north americaSouthern california

Biocept Names Antonino Morales as President and Chief Executive Officer

Samuel D. Riccitelli resigns as interim President and CEO, and Director . | June 20, 2023

United statesM faye wilsonSamueld riccitelliRobert walshBiocept incArthur andersenUniversity of southern californiaAudit committeeAntonino moralesChief executive officerChief financial officerVice presidentChief financialMazda north americaSouthern california

Biocept : Modification to Rights of Security Holders - Form 8-K

8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 . | May 16, 2023

State of delawareUnited statesSan diegoSamueld riccitelliSecurities exchangeBiocept incNasdaq stock marketCertificate of incorporation biocept incSecurities exchange actTrim roadZip codeSecurities actExchange actRestated certificateEffective timeNasdaq capital market

Biocept Reports First Quarter 2023 Financial Results

Biocept, Inc. , a leading provider of molecular diagnostic assays, products and services, reports financial results for the three months ended March 31, 2023 and provides a business. | May 10, 2023

United statesLos angelesSamueld riccitelliBiocept incExchange commissionSan francisco bay areaPrivate securities litigation reform actAnnual reportQuarterly reportThree months ended marchNc stock exchangePress releaseRovides bioc us09072v5012